Brief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
09/12/2016 22:03
Dec 9 (Reuters) - Parnell Pharmaceuticals Holdings Ltd
PARN.O
* Decision has been made to facilitate substantial cost
savings consistent with previously stated goals of becoming
profitable in 2017.
* Announces intention to move from Nasdaq OMX global market
and expects to move to OTC pink open market
Source text for Eikon: ID:nGNXNNLCUa
Further company coverage: PARN.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln